Works matching IS 11738804 AND DT 2023 AND VI 37 AND IP 6

Results: 10

Do the Outcomes of Clinical Efficacy Trials Matter in Regulatory Decision-Making for Biosimilars?

Published in:

BioDrugs, 2023, v. 37, n. 6, p. 855, doi. 10.1007/s40259-023-00631-4

By:

Kirsch-Stefan, Nadine;
Guillen, Elena;
Ekman, Niklas;
Barry, Sean;
Knippel, Verena;
Killalea, Sheila;
Weise, Martina;
Wolff-Holz, Elena

Publication type:

Article

Real-World Clinical Outcomes of Bevacizumab-awwb Biosimilar versus Bevacizumab Reference Product in Patients with Metastatic Colorectal Cancer.

Published in:

BioDrugs, 2023, v. 37, n. 6, p. 891, doi. 10.1007/s40259-023-00624-3

By:

Pham, Catherine;
Niu, Fang;
Delate, Thomas;
Buchschacher Jr, Gary L.;
Li, Yan;
Ekinci, Ekim;
Le, Kim;
Hui, Rita L.

Publication type:

Article

Malaria Vaccines: Progress to Date.

Published in:

BioDrugs, 2023, v. 37, n. 6, p. 737, doi. 10.1007/s40259-023-00623-4

By:

Stanisic, Danielle I.;
Good, Michael F.

Publication type:

Article

Enzyme Engineering Strategies for the Bioenhancement of l-Asparaginase Used as a Biopharmaceutical.

Published in:

BioDrugs, 2023, v. 37, n. 6, p. 793, doi. 10.1007/s40259-023-00622-5

By:

Miranda, Javiera;
Lefin, Nicolás;
Beltran, Jorge F.;
Belén, Lisandra Herrera;
Tsipa, Argyro;
Farias, Jorge G.;
Zamorano, Mauricio

Publication type:

Article

Acute Kidney Injury from Intravitreal Anti-vascular Endothelial Growth Factor Drugs: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

Published in:

BioDrugs, 2023, v. 37, n. 6, p. 843, doi. 10.1007/s40259-023-00621-6

By:

Tsao, Yu-Chien;
Chen, Ting-Ying;
Wang, Li-An;
Lee, Chia-Chun;
Lee, Wan-Ju Annabelle;
Hsu, Sheng-Min;
Lai, Chi-Chun;
Shao, Shih-Chieh;
Hung, Jia-Horung;
Lai, Edward Chia-Cheng

Publication type:

Article

Patients' Perceptions of Biosimilars: A Systematic Review.

Published in:

BioDrugs, 2023, v. 37, n. 6, p. 829, doi. 10.1007/s40259-023-00620-7

By:

Wu, Qiyou;
Wang, Zhitao;
Wang, Xin;
Yu, Hui;
Sun, Jing

Publication type:

Article

Recurrent Clostridioides difficile Infection: Current Clinical Management and Microbiome-Based Therapies.

Published in:

BioDrugs, 2023, v. 37, n. 6, p. 757, doi. 10.1007/s40259-023-00617-2

By:

Berry, Parul;
Khanna, Sahil

Publication type:

Article

The PROPER Study: A 48-Week, Pan-European, Real-World Study of Biosimilar SB5 Following Transition from Reference Adalimumab in Patients with Immune‐Mediated Inflammatory Disease.

Published in:

BioDrugs, 2023, v. 37, n. 6, p. 873, doi. 10.1007/s40259-023-00616-3

By:

Müller-Ladner, Ulf;
Dignass, Axel;
Gaffney, Karl;
Jadon, Deepak;
Matucci-Cerinic, Marco;
Lobaton, Triana;
Carron, Philippe;
Gisbert, Javier P.;
Pande, Ira;
Utzinger, Maximilian;
Addison, Janet

Publication type:

Article

Neoadjuvant Immunotherapy for Non-Small Cell Lung Cancer.

Published in:

BioDrugs, 2023, v. 37, n. 6, p. 775, doi. 10.1007/s40259-023-00614-5

By:

Sanber, Khaled;
Rosner, Samuel;
Forde, Patrick M.;
Marrone, Kristen A.

Publication type:

Article

Treatment with Biologic Drugs in Pediatric Behçet's Disease: A Comprehensive Analysis of the Published Data.

Published in:

BioDrugs, 2023, v. 37, n. 6, p. 813, doi. 10.1007/s40259-023-00613-6

By:

Batu, Ezgi Deniz;
Sener, Seher;
Cam, Veysel;
Aktay Ayaz, Nuray;
Ozen, Seza

Publication type:

Article